Newsletter Archive

  1. 09.28.16 -- How Health Systems Will Manage Biosimilars: Implications For Manufacturers
    9/28/2016
    09/28/16 BioProcess Online Newsletter
  2. 09.26.16 -- An Analysis Of The Global Generics Market
    9/26/2016
    09/26/16 BioProcess Online Newsletter
  3. 09.21.16 -- Establish Sample Sizes For Process Validation Using C=0 Sampling Plans
    9/21/2016

    09/21/16 BioProcess Online Newsletter

  4. 09.19.16 -- Divergent Approaches To Stem Cell Regulation
    9/19/2016

    09/19/16 BioProcess Online Newsletter

  5. 09.16.16 -- A Working Intro To Six Sigma For Biopharma Manufacturers
    9/16/2016

    09/16/16 BioProcess Online Newsletter

  6. 09.15.16 -- How Pacira Pharma Is Working To Help Curb The Opioid Epidemic
    9/15/2016

    09/15/16 BioProcess Online Newsletter

  7. 09.14.16 -- Are You Overlooking This Critical Component Of Bioprocess Facility Design?
    9/14/2016

    09/14/16 BioProcess Online Newsletter

  8. 09.07.16 -- Implement QbD Early For Biological Product Development
    9/13/2016

    09/13/16 BioProcess Online Newsletter

  9. 09.05.16 -- Anti-TNF Biosimilars In Europe: What Matters Beyond Price?
    9/5/2016

    09/05/16 BioProcess Online Newsletter

  10. 08.31.16 -- Data Integrity: Surveying The Current Regulatory Landscape
    8/31/2016

    08/31/16 BioProcess Online Newsletter